The Alliance Drug Discovery Collaborative Research Network led by Professor Francisco Quintana at Harvard’s Brigham and Women’s Hospital has reported that a subset of brain cells (astrocytes) may be directed…read more
Progressive MS Alliance Collaborative Research Network Study Shows that Stem Cells Derived from Skin Cells of People with MS Make Normal Nerve-Insulating Myelin Results Open More Possibilities for Myelin Repairread more
The MBIE Science Whitinga Fellowship is aimed at supporting excellent early career researchers impacted by COVID-19 in the New Zealand research science system. This is a one-off initiative and will…read more
MS Research Australia has funded 3 projects in the 2021 grant round looking at the impact of dietary factors in MS. The projects cover a wide range of possible effects…read more
A recent scientific publication has been touted as highlighting a potential vaccine for MS by some media outlets. So, what does this mean? And how does this tie in with…read more
The projects cover a wide range of topics and research areas, including research into COVID-19 in people with MS in Australia.read more
This article, written by the Journal of Multiple Sclerosis and related disorders, (MSARD) includes data from clinical trials, post marketing safety surveillance and a US electronic medical records database, Optum.read more
Pharmac have released public consultation on a proposal to widen access to funded multiple sclerosis treatments and transition access from the Multiple Sclerosis Treatment Assessment Committee (MSTAC) Panel to a…read more
These webinars cover the latest in MS research. Highlights include Dr Wallace Brownlee, who dialled in from London to update us on HSCT treatments for MS, and Justin O’Sullivan speaking…read more
New data on the long term benefits of Ocrelizumab for PPMS has recently been published 29 October 2020 on the Lancet Ocrelizumab is currently funded for RRMS in New Zealand…read more
Note: This article was originally published on www.multiplesclerosisnewstoday.com, written by Marta Figueiredo and fact checked by Patrícia Silva, PHD. MD1003, MedDay Pharmaceuticals’ high-dose biotin therapy, failed to significantly improve functional…read more
A survey exploring participants’ perspectives of people living with Multiple Sclerosis to better understand adjustment to diagnosis and the role of psychological support in the patient journey.read more
Exploring patterns of medicinal cannabis use prior to implementation of the new Medicinal Cannabis Scheme (MCS) in New Zealand.read more
Questionnaire for persons with multiple sclerosis: language, communication, and quality of liferead more
Positive psychological health and self-compassion are important for positive outcomes for people with MS and protect them against poorer outcomes.read more
You are invited to take part in a study, exploring your views on the value of a telehealth complex-wheelchair assessment service.read more
PROMS comes to another key milestone on the road to its mission, announcing members of the Executive Committee and Scientific Steering Committee.read more
The latest developments in MS research streamed live.read more
Join us to hear about the latest development in MS research happening nationally and internationally.read more
ECTRIMS launch for new patient-centred initiativeread more
